infect
alreadi
affect
signific
number
spanish
patient
rrt
mainli
ich
hospit
rate
high
mortal
high
age
develop
pneumonia
factor
associ
mortal
la
recient
de
la
pandemia
por
el
coronaviru
ha
impactado
de
forma
muy
important
en
la
gener
lo
pacient
en
tratamiento
renal
sustitutivo
tr
han
sido
ajeno
esta
por
su
resultan
especialment
vulner
presentamo
lo
resultado
del
del
registro
de
la
sen
el
registro
funcionar
el
de
marzo
de
recog
variabl
dato
del
contagio
tratamiento
desenlac
se
trata
de
un
registro
line
lo
pacient
fueron
diagnosticado
de
por
en
base
lo
resultado
de
la
pcr
del
viru
realizada
tanto
en
pacient
que
manifestado
compat
signo
sospechoso
como
en
aquello
lo
que
se
hecho
como
cribado
tra
contacto
conocido
con
otro
enfermo
fecha
de
abril
el
registro
de
dato
de
pacient
procedent
de
toda
la
comunidad
la
modalidad
de
tr
representada
es
la
en
centro
hdc
seguida
de
lo
pacient
trasplantado
la
de
es
similar
la
gener
un
porcentaj
muy
elevado
ingreso
hospitalario
un
en
unidad
de
cuidado
intensivo
lo
tratamiento
utilizado
fueron
hidroxicloroquina
lopinavirritonavir
esteroid
la
mortalidad
es
elevada
alcanza
el
lo
pacient
fallecido
estaban
con
frecuencia
en
hdc
desarrollaban
frecuentement
en
meno
ocasion
lopinavirritonavir
esteroid
la
edad
la
se
asociaban
de
forma
independient
al
riesgo
de
fallec
la
por
afecta
ya
un
important
de
pacient
en
tr
fundamentalment
aquello
que
en
hdc
la
tasa
de
son
muy
elevada
la
mortalidad
es
elevada
la
edad
el
desarrollo
de
son
factor
asociado
mortalidad
palabra
clave
registro
tratamiento
renal
sustitutivo
sociedad
de
recent
appear
coronaviru
pandem
signific
impact
gener
popul
patient
renal
replac
therapi
rrt
unawar
situat
due
characterist
especi
vulner
present
result
analysi
registri
spanish
societi
nephrolog
registri
began
oper
march
collect
epidemiolog
variabl
contagion
diagnosi
data
sign
symptom
treatment
outcom
onlin
registri
patient
diagnos
infect
base
result
pcr
viru
carri
patient
manifest
compat
symptom
suspici
sign
well
undergon
screen
contact
acquaint
anoth
patient
april
registri
data
patient
autonom
commun
repres
form
tr
incent
hemodialysi
ich
follow
transplant
patient
symptom
similar
gener
popul
high
percentag
requir
hospit
admiss
intens
care
unit
use
treatment
hydroxychloroquin
lopinavirritonavir
steroid
mortal
high
reach
deceas
patient
frequent
ich
develop
pneumonia
frequent
receiv
less
frequent
lopinavirritonavir
steroid
age
pneumonia
independ
associ
risk
death
late
author
peopl
republ
china
report
world
health
organ
sever
case
pneumonia
unknown
etiolog
wuhan
citi
locat
chines
provinc
hubei
later
found
infect
caus
new
coronaviru
call
viru
caus
variou
clinic
manifest
includ
term
includ
respiratori
symptom
differ
sever
common
cold
sever
pneumonia
respiratori
distress
syndrom
septic
shock
multipl
organ
failur
sinc
viru
spread
throughout
world
date
almost
million
peopl
contamin
april
unit
state
countri
confirm
case
follow
spain
itali
germani
franc
emerg
pandem
demand
special
care
vulner
group
peopl
among
chronic
kidney
diseas
ckd
patient
especi
requir
renal
replac
therapi
rrt
sinc
begin
pandem
spanish
societi
nephrolog
sen
start
work
togeth
ministri
health
nephrolog
servic
across
countri
patient
associ
scientif
societi
idea
develop
conting
plan
specif
protocol
gain
inform
knowledg
new
seriou
diseas
one
first
project
develop
first
week
pandem
affect
spain
gener
specif
registri
patient
form
rrt
spain
collect
effort
result
sen
registri
object
manuscript
present
result
first
analysi
registri
week
data
collect
j
u
r
n
l
p
r
e
p
r
f
registri
began
oper
march
week
committe
expert
creat
decid
variabl
includ
registri
select
variabl
gener
registri
immedi
simpl
desir
incorpor
mani
variabl
possibl
acquir
larg
amount
inform
howev
complex
drawback
greater
number
variabl
lower
degre
implement
furthermor
current
nephrologist
nephrolog
servic
high
demand
even
signific
number
profession
affect
coronaviru
reason
decid
choos
minimum
set
variabl
would
give
us
perspect
impact
sar
pandem
patient
rrt
spain
furthermor
inform
collect
line
registri
european
renal
associ
european
dialysi
transplant
associ
eraedta
eventu
data
could
unifi
european
level
satisfi
demand
epidemiolog
variabl
modal
renal
replac
therapi
contagion
inform
diagnosi
data
accompani
symptom
treatment
outcom
includ
registri
anonym
registri
meet
requir
impos
legisl
author
oper
request
region
ethic
committe
princip
asturia
registri
sen
format
line
access
websit
societi
wwwsenefroorg
prior
identif
person
access
site
user
registri
access
patient
data
enter
rest
inform
complet
databas
manag
coordin
registri
member
sen
upon
written
request
prior
author
expert
committe
patient
diagnos
infect
base
pcr
result
carri
patient
symptom
suggest
infect
screen
contact
anoth
infect
patient
registri
remain
oper
long
current
coronaviru
pandem
situat
maintain
period
analyz
inform
record
carri
obtain
conclus
impact
infect
rrt
patient
spain
effect
differ
strategi
deal
diseas
result
present
correspond
analysi
data
record
april
continu
variabl
express
mean
standard
deviat
categor
variabl
percentag
baselin
valu
compar
use
test
chi
squar
appropri
koimogorovsmirnov
test
use
determin
data
normal
distribut
linear
logist
regress
model
use
know
factor
associ
mortal
p
valu
less
consid
signific
statist
packag
spss
window
spss
inc
chicago
il
use
analyz
result
april
data
patient
rrt
document
coronaviru
infect
enter
registri
patient
health
center
scatter
throughout
spain
region
call
autonom
commun
report
case
tabl
madrid
present
largest
number
case
follow
catalonia
castilla
la
mancha
andalusia
averag
age
infect
patient
year
two
third
male
patient
hemodialysi
center
hdc
follow
transplant
patient
tx
much
less
common
periton
dialysi
pd
patient
report
two
case
home
hemodialysi
hhd
figur
three
ten
infect
patient
known
prior
contact
someon
els
infect
percentag
slightli
rose
case
patient
hdc
pd
case
tx
patient
averag
incub
period
patient
known
prior
contact
day
regard
clinic
manifest
tabl
patient
fever
twothird
symptom
upper
respiratori
infect
dyspnea
almost
quarter
gastrointestin
symptom
asymptomat
frequent
complic
develop
pneumonia
patient
also
lymphopenia
high
percentag
regist
patient
requir
hospit
admiss
admit
intens
care
unit
icu
almost
two
third
requir
mechan
ventil
averag
length
hospit
admiss
contempl
cure
patient
day
commonli
use
treatment
tabl
hydroxychloroquin
combin
lopinavirritonavir
third
patient
receiv
drug
togeth
steroid
interferon
tocilizumab
use
less
frequent
date
patient
die
regist
patient
characterist
patient
reflect
tabl
compar
cure
patient
deceas
older
often
hdc
develop
frequent
pneumonia
frequent
lopinavirritonavir
steroid
prescrib
less
frequent
renin
angiotensin
aldosteron
system
raa
inhibitor
infect
characterist
patient
dialysi
includ
hdc
hhd
pd
transplant
differ
tabl
transplant
patient
younger
frequent
hospit
admiss
ward
icu
develop
pneumonia
greater
number
transplant
patient
treat
lopinavirritonavir
hidroxychloroquin
steroid
tocilizumab
also
receiv
raa
inhibitor
frequent
infect
final
percent
death
less
transplant
dialysi
patient
analyz
factor
associ
mortal
transplant
dialysi
patient
transplant
patient
age
develop
pneumonia
independ
associ
mortal
tabl
dialysi
patient
age
pneumonia
factor
associ
mortal
also
found
benefici
effect
hydroxychloroquin
tabl
final
cure
infect
report
patient
averag
time
elaps
curat
day
patient
die
rest
remain
situat
activ
infect
tabl
analysi
data
collect
first
three
week
registri
sen
show
infect
affect
signific
number
spanish
patient
rrt
mainli
hdc
rate
hospit
admiss
high
mortal
elev
age
develop
pneumonia
risk
factor
mortal
use
hydroxychloroquin
could
protect
effect
least
dialysi
patient
spain
infect
spread
throughout
autonom
commun
accord
data
suppli
ministri
health
incid
particularli
high
madrid
catalonia
castilla
la
mancha
castilla
similarli
accord
data
sen
registri
infect
patient
rrt
mainli
region
although
castilla
report
fewer
case
would
correspond
due
global
number
infect
commun
lowest
overal
number
infect
cantabria
murcia
extremadura
canari
island
princip
asturia
also
report
lower
number
patient
rrt
mean
age
patient
infect
match
mean
age
patient
rrt
entir
popul
rrt
infect
hd
patient
also
significantli
older
transplant
pd
patient
gener
popul
appear
coronaviru
affect
male
femal
case
patient
rrt
also
men
infect
could
reflect
greater
number
men
rrt
program
despit
fact
half
spanish
patient
rrt
transplant
spread
frequent
patient
hd
center
fact
may
surpris
hd
patient
fail
fulfil
regulatori
confin
sinc
move
hospit
dialysi
center
time
per
week
infrequ
use
public
transport
moreov
number
patient
undergo
hdc
live
nurs
home
place
frequent
infect
despit
immunosuppress
transplant
patient
repres
one
third
regist
infect
patient
final
note
patient
periton
dialysi
especi
hhd
repres
low
rate
infect
patient
although
represent
total
rrt
patient
spain
rel
low
far
clinic
manifest
differ
report
gener
popul
frequent
manifest
fever
symptom
upper
respiratori
infect
symptom
similar
frequenc
observ
retrospect
studi
includ
almost
patient
infect
rrt
quarter
patient
also
report
gastrointestin
symptom
frequent
gener
popul
shown
previous
mention
studi
contrast
author
show
rate
gastrointestin
symptom
even
higher
patient
moreov
first
case
infect
hemodialysi
patient
unit
state
present
diarrhea
first
symptom
infect
differ
form
screen
diagnosi
popul
may
caus
nonuniform
result
hospit
rate
patient
high
exceed
case
publish
studi
gener
popul
reveal
consider
lower
rate
hospit
howev
taken
consider
patient
rrt
older
comorbid
whichundoubtedli
result
deterior
clinic
situat
three
week
ago
result
metaanalysi
includ
publish
studi
patient
publish
conclud
chronic
kidney
diseas
risk
factor
develop
sever
infect
one
possibl
explan
ckd
wors
prognosi
lie
role
lymphocyt
recoveri
infect
known
uremia
deterior
lymphocyt
granulocyt
function
may
alter
defens
mechan
viru
hospit
admiss
frequent
among
transplant
patient
compar
dialysi
also
admiss
icu
seem
immunosuppress
could
play
role
mortal
high
dialysi
patient
infect
higher
risk
die
transplant
patient
circumst
probabl
relat
older
age
comorbid
variabl
record
registri
last
report
ministri
health
april
mortal
age
group
year
half
found
dialysi
patient
registri
high
risk
complic
patient
rrt
must
taken
consider
analysi
factor
independ
associ
risk
death
show
age
develop
pneumonia
determin
wors
prognosi
furthermor
group
patient
dialysi
use
hydroxychloroquin
associ
lower
rate
death
howev
signific
last
find
requir
studi
larger
number
patient
present
controversi
benefici
effect
hydroxychloroquin
vitro
studi
drug
shown
activ
variou
virus
includ
coronavirus
influenza
french
studi
found
benefit
use
number
patient
limit
contrast
anoth
studi
china
find
patient
treat
hydroxychloroquin
better
recoveri
rate
studi
benefici
effect
hydroxychloroquin
found
dialysi
transplant
patient
nevertheless
registri
show
hydroxychloroquin
commonli
use
drug
sarscov
use
frequent
transplant
dialysi
patient
ongo
control
studi
show
use
drug
benefici
benefit
raa
inhibitor
controversi
initi
public
warn
possibl
use
drug
indic
treatment
hypertens
heart
failur
ischem
heart
diseas
etc
may
increas
risk
infect
ration
infect
cell
viru
bind
angiotensin
ii
convert
enzym
ace
enzym
appear
overexpress
subject
ace
inhibitor
angiotensin
ii
receptor
antagonist
ara
howev
experi
anim
model
suggest
use
mitig
infect
attenu
angiotensin
iimedi
acut
lung
injuri
block
angiotensin
ii
type
receptor
recent
metaanalysi
suggest
benefici
effect
ara
sever
pneumonia
elderli
patient
reason
health
author
recommend
maintain
indic
drug
time
present
report
week
period
data
collect
registri
case
cure
shown
activ
infect
come
week
know
final
outcom
patient
inform
provid
knowledg
effect
rrt
patient
work
would
possibl
without
particip
mani
colleagu
collabor
differ
manner
collect
analysi
data
name
collabor
shown
annex
j
u
r
n
l
p
r
e
p
r
f
